Cargando…
Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitors: A report of five cases
Bullous pemphigoid (BP) is an autoimmune blistering skin disorder. Recently, BP induced by dipeptidyl peptidase‐4 (DPP‐4) inhibitors has been a concern. Although DPP‐4 inhibitors are commonly used in the Asian population because of their safety and efficacy, BP associated with DPP‐4 inhibitors is so...
Autores principales: | Yoshiji, Satoshi, Murakami, Takaaki, Harashima, Shin‐ichi, Ko, Rie, Kashima, Riko, Yabe, Daisuke, Ogura, Masahito, Doi, Kentaro, Inagaki, Nobuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835473/ https://www.ncbi.nlm.nih.gov/pubmed/28520234 http://dx.doi.org/10.1111/jdi.12695 |
Ejemplares similares
-
Bullous pemphigoid with dipeptidyl peptidase‐4 inhibitors: Clinical features and pathophysiology
por: Murakami, Takaaki, et al.
Publicado: (2019) -
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
por: Tasanen, Kaisa, et al.
Publicado: (2019) -
Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor
por: Kano, Yasuhiro, et al.
Publicado: (2022) -
Co-medications and dipeptidyl peptidase-4 inhibitors associated bullous pemphigoid()()
por: Gravani, Agoritsa, et al.
Publicado: (2021) -
Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor – A case report
por: Karthik, S, et al.
Publicado: (2019)